Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients.
Publication
, Journal Article
Willett, CG; Czito, BG
Published in: Ann Surg Oncol
October 2008
Duke Scholars
Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
October 2008
Volume
15
Issue
10
Start / End Page
2636 / 2638
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Remission Induction
- Rectal Neoplasms
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Neoadjuvant Therapy
- Humans
- Disease-Free Survival
- Combined Modality Therapy
Citation
APA
Chicago
ICMJE
MLA
NLM
Willett, C. G., & Czito, B. G. (2008). Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients. Ann Surg Oncol, 15(10), 2636–2638. https://doi.org/10.1245/s10434-008-0058-0
Willett, Christopher G., and Brian G. Czito. “Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients.” Ann Surg Oncol 15, no. 10 (October 2008): 2636–38. https://doi.org/10.1245/s10434-008-0058-0.
Willett CG, Czito BG. Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients. Ann Surg Oncol. 2008 Oct;15(10):2636–8.
Willett, Christopher G., and Brian G. Czito. “Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients.” Ann Surg Oncol, vol. 15, no. 10, Oct. 2008, pp. 2636–38. Pubmed, doi:10.1245/s10434-008-0058-0.
Willett CG, Czito BG. Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients. Ann Surg Oncol. 2008 Oct;15(10):2636–2638.
Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
October 2008
Volume
15
Issue
10
Start / End Page
2636 / 2638
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Remission Induction
- Rectal Neoplasms
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Neoadjuvant Therapy
- Humans
- Disease-Free Survival
- Combined Modality Therapy